Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Cerus Inks FDA Contract, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

Cerus Corp (CERS)  More Company Research Source: Seeking Alpha
Last cerus corp earnings: 2/20 04:01 pm Check Earnings Report
PDF Cerus Corporation inks FDA contract for Pathogen Reduction technologyCerus Corporation (CERSannouncedCerus is active in the field of blood products. It aims to develop and supply vital technologies and pathogen-protected blood components. Its main customer base consists of blood centers, hospitals and ultimately patients. Dr. Nina Mufti, program leader for both the Whole Blood and Red Blood Cell programs at Cerus said, “A whole blood PR solution would complement Cerus’ portfolio of marketed pathogen reduction products for platelets and plasma, as well as its INTERCEPT Red Blood Cell (RBCThe company’s lead product is INTERCEPT Blood System which delivers the full spectrum of blood transfusion products. It is the only company in blood transfusion segment to receive both the FDA approval and CE Mark for pathogen reduction of both plasma components and platelet. The system is currently available in the United States, Europe, the Commonwealth of Independent States, the Middle East and sele [Read more]
Impact snapshot Event time: CERS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
CERS alerts
from News Quantified
Opt-in for
CERS alerts

from News Quantified
Opt-in for
CERS alerts

from News Quantified